• Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells models

    2 monthes ago - By News Medical

    In a recent study posted to the bioRxiv* preprint server, researchers in Australia explored the molecular mechanisms of the pulmonary and cardiac complications caused by severe acute respiratory syndrome coronavirus 2 infection using human stem-cell-derived cardiac and lung cells.
    Read more ...

     

  • First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

    2 monthes ago - By News Medical

    In a recent study posted to the bioRxiv* preprint server, researchers from Germany and the United States analyzed the association between exposure to severe acute respiratory syndrome coronavirus 2 Omicron BA.4/BA.5 spike glycoprotein and pan-Omicron neutralization.
    Read more ...

     

  • First real-world study shows the effectiveness of mRNA COVID-19 vaccines during pregnancy

    2 monthes ago - By News Medical

    The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy.
    Read more ...

     

  • Review says dose of approved COVID-19 vaccines based on weak evidence

    2 monthes ago - By News Medical

    A recent study posted to the medRxiv* preprint server reviewed early-phase dose-finding trials to examine the study design, safety, and early antibody response data on approved coronavirus disease 2019 vaccines and gain insights on design improvements for future candidate COVID-19 vaccine clinical trials.
    Read more ...

     

  • Study looks at boosting with variant-derived COVID vaccine

    2 monthes ago - By News Medical

    In a recent study posted to bioRxiv*, researchers at Washington University School of Medicine, St. Louis, demonstrated that severe acute respiratory syndrome coronavirus 2 vaccine booster elicits robust germinal center B cell responses.
    Read more ...